ACA
MDGL icon

Avoro Capital Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$567M Sell
1,875,000
-147,222
-7% -$44.6M 9.94% 4
2025
Q1
$670M Sell
2,022,222
-6,778
-0.3% -$2.25M 10.46% 4
2024
Q4
$626M Hold
2,029,000
8.86% 4
2024
Q3
$431M Sell
2,029,000
-26,555
-1% -$5.64M 6.28% 5
2024
Q2
$576M Buy
2,055,555
+111,111
+6% +$31.1M 7.67% 2
2024
Q1
$519M Buy
1,944,444
+55,556
+3% +$14.8M 6.06% 5
2023
Q4
$437M Buy
1,888,888
+333,888
+21% +$77.3M 6.04% 5
2023
Q3
$227M Buy
1,555,000
+39,849
+3% +$5.82M 3.54% 12
2023
Q2
$350M Sell
1,515,151
-151,515
-9% -$35M 4.75% 6
2023
Q1
$404M Buy
1,666,666
+6,666
+0.4% +$1.61M 5.99% 6
2022
Q4
$482M Buy
1,660,000
+125,000
+8% +$36.3M 7.2% 4
2022
Q3
$99.8M Hold
1,535,000
1.84% 15
2022
Q2
$110M Buy
1,535,000
+110,000
+8% +$7.87M 2.17% 13
2022
Q1
$140M Hold
1,425,000
2.55% 15
2021
Q4
$121M Hold
1,425,000
2.06% 14
2021
Q3
$114M Hold
1,425,000
1.79% 16
2021
Q2
$139M Hold
1,425,000
2.41% 12
2021
Q1
$167M Buy
1,425,000
+200,000
+16% +$23.4M 2.88% 10
2020
Q4
$136M Buy
1,225,000
+335,000
+38% +$37.2M 2.35% 13
2020
Q3
$106M Buy
890,000
+540,000
+154% +$64.1M 1.5% 14
2020
Q2
$39.6M Buy
350,000
+1,000
+0.3% +$113K 0.78% 25
2020
Q1
$23.3M Hold
349,000
0.79% 27
2019
Q4
$31.8M Sell
349,000
-11,000
-3% -$1M 0.93% 19
2019
Q3
$31M Hold
360,000
1.29% 20
2019
Q2
$37.7M Buy
360,000
+50,000
+16% +$5.24M 1.3% 18
2019
Q1
$38.8M Buy
310,000
+85,000
+38% +$10.6M 1.68% 18
2018
Q4
$25.4M Sell
225,000
-238,000
-51% -$26.8M 1.52% 15
2018
Q3
$99.1M Sell
463,000
-26,536
-5% -$5.68M 4.55% 7
2018
Q2
$137M Buy
+489,536
New +$137M 5.27% 6